Application of uridine diphosphate glucuronic acid in the preparation of anti-aging drugs

Through the Cialis elegans model, it was found that uridine diphosphoric glucuronic acid inhibited the insulin receptor DAF-2 and activated DAF-16 and HSF-1, which solved the insufficient research on nucleotide metabolism in aging regulation, and achieved prolonged life span and The effects of slowing down aging provide new value for anti-aging drugs.

CN116036113BActive Publication Date: 2024-11-29JINAN UNIVERSITY
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202211483336.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-11-24
Publication Date
2024-11-29
Estimated Expiration
2042-11-24

AI Technical Summary

Technical Problem

The existing metabolic intermediates have insufficient research on aging regulation, especially the regulatory effect of nucleotide metabolism on aging has not been fully explored.

Method used

By taking C. elegans as a model, it was found that uridine diphosphate glucuronic acid has anti-aging effects. The specific mechanism is to inhibit the insulin receptor DAF-2, activate the downstream transcription factors DAF-16 and HSF-1, and regulate the insulin signaling pathway. Delay aging.

Benefits of technology

For the first time, the anti-aging mechanism of glucuronate uridine diphosphate was elucidated, providing a theoretical basis for its development of anti-aging drugs, extending the lifespan of nematodes and slowing the emergence of aging-related phenotypes.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116036113B_ABST
    Figure CN116036113B_ABST
Patent Text Reader

Abstract

The present invention belongs to the field of biomedicine technology, and specifically relates to the use of UDP-glucuronic acid in the preparation of anti-aging drugs. Experimental studies have confirmed that UDP-glucuronic acid can effectively delay the aging of Caenorhabditis elegans, and its extension of the life span of nematodes is concentration-dependent. Through mechanism studies, it was found that the anti-aging effect of UDP-glucuronic acid depends on the participation of the insulin receptor DAF‑2 and its downstream transcription factors DAF‑16 and HSF‑1, which is mainly achieved by regulating the insulin signaling pathway, and can be used to prepare anti-aging drugs / health products.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of biomedicine technology, and more specifically, relates to the application of uridine diphosphate glucuronic acid in the preparation of anti-aging drugs. Background Art

[0002] Human health and aging have been one of the most concerned issues for people since ancient times, and one of the most important issues to be solved by scientific research. Aging is the most common basic biological process that people see, which is manifested as structural degeneration and functional decline, reduced adaptability and resistance, and ultimately leads to death. Aging is the main risk factor for many fatal diseases in humans, including cardiovascular disease, cancer, diabetes, chronic inflammation in the elderly, emphysema, osteoporosis in the elderly and neurodegenerative diseases. As the proportion of the elderly population continues to increase, how to enter the elderly stage in a healthy way has become a vital issue. Therefore, clarifying the root cause of aging and finding drugs to fight aging will help us solve this fascinating biological problem that has a huge impact on society.

[0003] Metabolism is an inseparable part of the body. All biological processes of the body are inseparable from the influence of metabolism. Metabolism also plays a vital role in aging. Therefore, it is of great value and significance to conduct in-depth research on metabolic intermediates to expand their application in the fields of biomedicine and health. For example, Chinese patent application CN104814974A discloses that nicotinamide mononucleotide has significant anti-aging effects; Chinese patent application CN113476470A discloses that 5'-nucleotides or mixtures thereof have the effects of preventing and treating cell cycle arrest, increasing NAD+ and / or L-glutamine content, and enhancing cell metabolism levels, thereby delaying cell aging; Chinese patent application CN112912500A discloses an antisense oligonucleotide that regulates ATXN2 expression in target cells and plays a role in treating a variety of neurodegenerative diseases. At present, the existing technology on the research of metabolic intermediates in intervening in aging is still very limited. Therefore, it is still necessary to further explore it and expand its application. Summary of the invention

[0004] The technical problem to be solved by the present invention is to overcome the defects and shortcomings of existing research on metabolic intermediates and provide the application of uridine diphosphate glucuronic acid in the preparation of anti-aging drugs.

[0005] The above-mentioned purpose of the present invention is achieved through the following technical solutions:

[0006] At present, research on metabolic regulation of aging has found that several important metabolic processes, including sugar metabolism, lipid metabolism, amino acid metabolism, etc., are involved in aging regulation, and exogenous supplementation of intermediate metabolites of these metabolic processes will affect the aging of the body. However, there are few reports on the regulatory effect of another important metabolic process-nucleotide metabolism on aging. The present invention uses Caenorhabditis elegans as a model and finds that uridine diphosphate glucuronic acid has an anti-aging effect in nematodes. Through mechanism analysis, it is found that the effect of uridine diphosphate glucuronic acid in delaying the aging of Caenorhabditis elegans is achieved by inhibiting the insulin receptor DAF-2, thereby activating the downstream transcription factors DAF-16 and HSF-1, and finally regulating the insulin signaling pathway.

[0007] Based on the above reasons, the present invention claims to protect the use of uridine diphosphate glucuronic acid in the preparation of anti-aging drugs.

[0008] Furthermore, the anti-aging is to inhibit the body's insulin receptors.

[0009] Furthermore, the insulin receptor is DAF-2.

[0010] Specifically, the uridine diphosphate glucuronic acid inhibits the body's insulin receptor by regulating the insulin signaling pathway.

[0011] Furthermore, the anti-aging effect is to activate the body's downstream transcription factors.

[0012] Furthermore, the downstream transcription factor is DAF-16.

[0013] Furthermore, the downstream transcription factor is HSF-1.

[0014] Specifically, the UDP-glucose regulates the insulin signaling pathway to inhibit the body's insulin receptors, thereby activating the body's downstream transcription factors.

[0015] Preferably, the effective concentration of UDP-glucuronic acid is 0.05 mM to 10 mM.

[0016] More preferably, the effective concentration of UDP-glucuronic acid is 0.1 mM to 2 mM.

[0017] Most preferably, the effective concentration of UDP-glucuronic acid is 0.5 mM.

[0018] Furthermore, the dosage form of the anti-aging drug is capsule, tablet, pill, granule, ointment, powder, injection, spray or oral solution.

[0019] The present invention has the following beneficial effects: the present invention is the first to discover that uridine diphosphate glucuronic acid has anti-aging effects, and preliminarily clarifies its anti-aging mechanism of action, develops new application value of uridine diphosphate glucuronic acid, and provides a theoretical basis for developing it as an anti-aging drug. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] Figure 1 Data showing that UDP-glucuronidase extends the lifespan of wild-type N2 Caenorhabditis elegans.

[0021] Figure 2 Figure 2. Data for UDP-glucuronidase-prolonged rapid locomotion cycle in wild-type N2 Caenorhabditis elegans.

[0022] Figure 3 The data graph shows that UDP-glucuronic acid extends the lifespan of nematodes by activating DAF-16; (A) shows the effect of UDP-glucuronic acid on the lifespan of the CF1038 daf-16 (mu86) mutant; (B) shows the effect of UDP-glucuronic acid on the transcription levels of the DAF-16 downstream target genes sod-3 and rgs-10.

[0023] Figure 4 The graph shows the effect of UDP-glucuronidase on the lifespan of the CB1370 daf-2 (e1370) mutant.

[0024] Figure 5 The data graph shows that UDP-glucuronic acid extends the lifespan of nematodes by activating HSF-1; (A) shows the effect of UDP-glucuronic acid on the lifespan of the PS3551 hsf-1 (sy441) mutant strain; (B) shows the effect of UDP-glucuronic acid on the transcription levels of HSF-1 downstream target genes hsp-16.2 and hsp-12.6.

[0025] The concentration values ​​of UDP-glucuronic acid added in the examples are expressed as "concentration value + UDP-GlcA" in the figures, such as 0.5 mM; in the figures, they are recorded as 0.5 mM UDP-GlcA, and the blank control group without adding UDP-glucose is recorded as Control. DETAILED DESCRIPTION

[0026] The present invention is further described below in conjunction with the accompanying drawings and specific examples, but the examples do not limit the present invention in any form. Unless otherwise specified, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the art.

[0027] Unless otherwise specified, the reagents and materials used in the following examples are commercially available.

[0028] The nematodes were wild-type N2 nematodes obtained from the Caenorhabditis Genetics Center (CGC).

[0029] Uracil-deficient Escherichia coli (OP50) was obtained from the Caenorhabditis Genetics Center (CGC).

[0030] CF1038 daf-16(mu86) is a DAF-16 loss-of-function mutant in nematodes.

[0031] CB1370 daf-2 (e1370) is a partial loss-of-function mutant of the insulin receptor DAF-2 in nematodes.

[0032] ps3551 hsf-1(sy441) is a HSF-1 loss-of-function mutant in nematodes.

[0033] UDP-GlcA is uridine diphosphate glucuronic acid.

[0034] Lifespan experiments or movement experiments require that the final statistical sample size must be greater than 60 normal deaths. Considering that there may be abnormal deaths such as nematode escape and genital pore protrusions during the entire experimental period, it is necessary to select more than 100 worms to perform the experiment.

[0035] Preliminary material preparation:

[0036] 1. M9 solution

[0037] Take 6 g, 3 g and 5 g of Na2HPO4, KH2PO4 and NaCl respectively, add deionized water to 1 L, sterilize at 121 ℃ for 20 min, and then add 1 mL of 1 M MgSO4 for later use.

[0038] 2. Preparation of Plates

[0039] (1) Preparation of NGM plates: Weigh 1.2 g NaCl, 1 g trypsin, and 6.8 g agar powder, add 400 mL deionized water, and autoclave at 121 °C for 20 min. After the sterilized culture medium has cooled slightly, add 4 mL KH2PO4 / K2HPO4 solution, 0.4 mL MgSO4 (1 mol / L) solution, 0.4 mL CaCl2 (1 mol / L) solution, and 0.4 mL cholesterol (5 mg / mL) solution to the culture medium in an ultra-clean workbench, mix well, and pour into a sterilized culture dish. After standing for a period of time, a common NGM (Nematode Growth Medium, NGM) plate is obtained.

[0040] (2) Preparation of NGM plates containing 0.5 mM UDP-glucuronic acid: Aseptically add 0.5 mM UDP-glucuronic acid (0.8 mL for a 6 cm diameter plate) to the solidified NGM plate. Let stand at room temperature for 12 h and then blow dry with sterile air to obtain the NGM plates containing 0.5 mM UDP-glucuronic acid. Place in a 4 °C refrigerator for later use.

[0041] (3) Preparation of FUDR plates: On the basis of NGM medium, add 0.4 mL of 0.1 mol / L 5-fluoro-2'-deoxyuridine (5-Fluoro- 2'-deoxyuridine, FUDR) solution filtered through a 0.22 μm filter membrane aseptically, mix and pour into a sterilized culture dish to make a FUDR plate with a FUDR concentration of 10 μM for subsequent lifespan experiments. The purpose of adding FUDR is to inhibit the production of nematode offspring.

[0042] (4) Preparation of FUDR plates containing different concentrations of UDP-glucuronic acid: Use sterile water to prepare different concentrations of UDP-glucuronic acid (0-10 mM) and add them to the solidified FUDR plates (for a 6 cm diameter plate, add 0.8 mL). After the plates are allowed to stand at room temperature for 12 h, they are blown dry with sterile air. The FUDR plates containing different concentrations of UDP-glucuronic acid are then placed in a 4 °C refrigerator for later use.

[0043] 3. Preparation of OP50 food for nematodes

[0044] Take a single clone of uracil-deficient Escherichia coli (OP50) from a LB (Luria-Bertani, LB) solid culture plate and inoculate it into LB liquid culture medium, and place it in a shaker at 200 rpm and 37 °C for 12 h. Concentrate the cultured OP50 to an appropriate concentration in a sterilized clean bench for later use.

[0045] According to the experimental requirements, on the clean bench, evenly spread the concentrated OP50 bacterial solution on the NGM plate and blow dry it to obtain the normal NGM plate for culturing nematodes; heat the concentrated OP50 at 65 °C for 30 min (the purpose is to inactivate OP50 and prevent OP50 from metabolizing the compound), then spread it on the plate to obtain the FUDR plate for lifespan or movement experiments, and store it in a refrigerator at 4 °C for later use. Note that the bacterial solution should be in a circular shape in the plate and cannot be spread on the edge of the culture dish to prevent the nematodes from escaping.

[0046] 4. Synchronization process of nematodes

[0047] Wash the nematodes and eggs on the NGM plate in the egg-laying stage with sterile water, suspend the nematodes and eggs in the liquid, collect them in a 15 mL centrifuge tube, add sterile water to 7 mL, and then add 3 mL of a mixed solution of 5M NaOH and 5% sodium hypochlorite in a ratio of 1:2 (prepare immediately before use), mix, and let the worms stand to lyse until there are no nematodes left in the tube. Then, centrifuge at 1150 g for 10 min to remove the lysis solution, wash twice with sterile water, add 10 mL of M9 solution to the tube, shake well, mix, and place it in a 20 ° C incubator overnight (more than 12 h) to synchronize the nematodes to the L1 stage. The nematodes synchronized to the L1 stage were taken out of the incubator, placed on ice for 10 min, centrifuged at 1800 g for 10 min, the supernatant was discarded, 1 mL of sterile water was added to resuspend the nematodes in the liquid, 0.1 mL of the suspension containing nematodes was pipetted with a pipette and dropped into the NGM culture dish, which was placed in a 20 °C constant temperature incubator for subsequent experiments.

[0048] Example 1 Effects of different concentrations of UDP-glucuronic acid on the lifespan of nematodes

[0049] 1. Purpose of the experiment

[0050] To investigate the effects of different concentrations of UDP-glucuronic acid on the lifespan of nematodes.

[0051] 2. Experimental methods

[0052] All lifespan experiments were conducted at 20 °C. Before the lifespan experiment, wild-type N2 nematodes were cultured on fresh NGM plates for 2 to 3 generations, and the nematodes were ensured not to have experienced any starvation stimulation. Then, they were synchronized according to the synchronization process of nematodes to obtain nematodes assimilated to the L1 stage, and the L1 stage nematodes were continued to be cultured on NGM plates until the late L4 or early adult stage. More than 100 nematodes in the late L4 or early adult stage were selected on FUDR plates, and control and experimental groups were set up. The control group was a normal FUDR plate, and the experimental group used a FUDR plate with 0.05 mM, 0.1 mM, 0.5 mM, 2 mM and 10 mM UDP-glucose. The first day of egg laying was recorded as the first day of adult lifespan. In order to ensure the efficacy of the drug throughout the life cycle, the nematodes in the control group and the experimental group were transferred to fresh corresponding FUDR plates every other day. The number of nematodes that survived was counted every day until all the nematodes died. In the lifespan statistics, if the nematode cannot respond to external mechanical stimulation (such as knocking on the plate), it is recorded as dead. Nematodes that crawl out of the plate, have genital pores protruding, or larvae hatching in the body are not counted as dead. The experimental results were analyzed by SPSS software, and the data were expressed by Kaplan-Meier survival curves. Statistical differences were calculated by log-rank test. Four biological replicates were performed for each group of lifespan experiments.

[0053] 3. Experimental results

[0054] The results are as follows Figure 1 As shown in Table 1, it was found that UDP-glucuronic acid can extend the lifespan of Caenorhabditis elegans, and the lifespan extension is concentration-dependent, among which 0.5 mM UDP-glucuronic acid has the best effect of extending the lifespan of nematodes.

[0055] Table 1 Effects of different concentrations of UDP-glucuronic acid on the lifespan of wild-type N2 Caenorhabditis elegans

[0056]

[0057] Table 1: The lifespan experiment was analyzed using SPSS software Kaplan-Meier, and the statistical difference (P value) was calculated using log-rank test; N is the number of nematodes included in the final statistical results of the experiment; # indicates that no calculation was performed (because P>0.05). The experiment was repeated 4 times independently.

[0058] Example 2 Effect of UDP-glucuronic acid on the movement of nematodes

[0059] 1. Purpose of the experiment

[0060] To explore the effect of UDP-glucuronic acid on the movement of nematodes. The extension of the lifespan of Caenorhabditis elegans is often accompanied by the improvement of aging-related phenotypes. To this end, the effect of UDP-glucose on the movement of nematodes, an aging-related phenotype, was analyzed.

[0061] 2. Experimental methods

[0062] Wild-type N2 nematodes were cultured on fresh NGM plates for 2 to 3 generations, and the nematodes were ensured not to experience any starvation stimulation. Then, the nematodes used for movement analysis were synchronized according to the synchronization process of nematodes to obtain nematodes assimilated to the L1 stage. The L1 stage nematodes were continued to be cultured on NGM plates until the late L4 or early adult stage. More than 100 nematodes in the late L4 or early adult stage were selected on FUDR plates, and control and experimental groups were set up. Among them, the control group was a common FUDR plate, and the experimental group used a FUDR plate with 0.5 mM UDP-glucose, which was cultured at 20 °C. The movement of nematodes was observed and counted every day. When the plate was tapped, if the nematodes crawled continuously like a sine curve, it was recorded as a fast movement stage, otherwise it was recorded as a slow movement stage. Consistent with the lifespan experiment, the nematodes were transferred to fresh plates every other day to ensure the efficacy of the drug. The movement results were statistically analyzed using a t-test.

[0063] 3. Experimental results

[0064] The results are as follows Figure 2 As shown, it was found that 0.5 mM UDP-glucuronic acid significantly prolonged the rapid movement period of nematodes, indicating that UDP-glucuronic acid slowed down the process of slowing down movement speed with aging, further confirming that UDP-glucuronic acid has the effect of extending the lifespan of Caenorhabditis elegans.

[0065] Example 3 Analysis of the mechanism of UDP-glucuronic acid delaying aging in nematodes

[0066] 1. Purpose of the experiment

[0067] To explore the mechanism by which uridine diphosphate glucuronide delays aging in nematodes.

[0068] 2. Experimental methods

[0069] All lifespan experiments were conducted at 20 °C. Before the lifespan experiment, CF1038 daf-16(mu86) mutant nematodes were cultured on fresh NGM plates for 2 to 3 generations, and the nematodes were not subjected to any starvation stimulation. Then, the nematodes used for the lifespan experiment were synchronized according to the synchronization process of nematodes to obtain nematodes assimilated to the L1 stage. The L1 stage nematodes were continued to be cultured on NGM plates until the late L4 or early adult stage. More than 100 nematodes in the late L4 or early adult stage were picked on FUDR plates, and control and experimental groups were set up. Among them, the control group was a normal FUDR plate, and the experimental group used a FUDR plate containing 0.5 mM UDP-glucose. The first day of egg laying was recorded as the first day of adult lifespan. In order to ensure the efficacy of the drug throughout the life cycle, the nematodes in the control group and the experimental group were transferred to fresh corresponding FUDR plates every other day. The number of nematodes that survived was counted every day until all the nematodes died. In the lifespan statistics, if the nematode cannot respond to external mechanical stimulation (such as knocking on the plate), it is recorded as dead. Nematodes that crawl out of the plate, have genital pores protruding, or larvae hatching in the body are not counted as dead. The experimental results were analyzed by SPSS software, and the data were expressed by Kaplan-Meier survival curves. Statistical differences were calculated by log-rank test. Three biological replicates were performed for each group of lifespan experiments.

[0070] 3. Experimental results

[0071] The results are as follows Figure 3 (A) and Table 2. First, the role of forkhead transcription factor DAF-16 / FOXO in UDP-glucuronide delaying aging in nematodes was analyzed. Through survival analysis of the DAF-16 functional loss-of-function mutant CF1038 daf-16 (mu86), it was found that UDP-glucuronide could not further extend the lifespan of the mutant.

[0072] Table 2 Effect of UDP-glucuronidase on the lifespan of the CF1038 daf-16 (mu86) mutant

[0073] UDP-glucuronic acid concentration Mean life span ± SEM (days) #timg#value % Elongation Number of samples Experiment 1 0 20.768±0.244 138 0.5 20.412±0.280 0.541 # 119 Experiment 2 0 20.870±0.264 117 0.5 20.495±0.301 0.638 # 107 Experiment 3 0 20.090±0.255 122 0.5 20.048±0.262 0.979 # 126

[0074] Table 2: The lifespan experiment was analyzed using SPSS software Kaplan-Meier, and the statistical difference (P value) was calculated using log-rank test; N is the number of nematodes included in the final statistical results of the experiment; # indicates that no calculation was performed (because P>0.05). The experiment was repeated three times independently.

[0075] Example 4 Analysis of the mechanism of UDP-glucuronic acid delaying aging in nematodes

[0076] 1. Purpose of the experiment

[0077] To explore the mechanism by which uridine diphosphate glucuronide delays aging in nematodes.

[0078] 2. Experimental methods

[0079] (1) Before RNA extraction and quantitative PCR (RT-qPCR) of nematodes, wild-type N2 nematodes were cultured on fresh NGM plates and synchronized according to the synchronization process of nematodes to obtain nematodes assimilated to the L1 stage. About 2,000 synchronized wild-type N2 nematodes at the L1 stage were cultured on NGM plates, and a control group and an experimental group were set up. The control group was a normal NGM plate, and the experimental group was an NGM plate containing 0.5 mM UDP-glucuronic acid. After culturing to the first day of adulthood, rinse and wash with M9 solution and collect. Centrifuge, aspirate all the supernatant, and place in liquid nitrogen for 10 s. Add 0.5 mL Trizol to fully homogenize and let stand at room temperature for 5 min.

[0080] (2) Add 0.2 mL of chloroform per 1 mL of Trizol solution, mix thoroughly, and let stand at room temperature for 10 min.

[0081] (3) Centrifuge at 4°C and 12,000 rpm for 15 min. The sample will separate into three layers. The upper layer is the RNA layer.

[0082] (4) Add an equal volume of isopropanol to the absorbed RNA solution, mix well, leave at room temperature for 10 min, and centrifuge at 4°C, 12,000 rpm for 10 min.

[0083] (5) Discard the waste liquid, add 1 mL of 75% ethanol to wash the precipitate (4°C, 20 min), centrifuge at 4°C, 12,000 rpm for 3 min, and discard the supernatant. The precipitate is RNA, dry it, and add 50 µL of 0.1% DEPC water to dissolve the RNA.

[0084] (6) Detect the purity and concentration of RNA, and then reverse the RNA into cDNA according to the operating procedures of the reverse transcription kit for quantitative PCR.

[0085] (7) Quantitative PCR was performed according to the instructions of the kit. The quantitative results were obtained using 2 -ΔΔCt The differential expression was calculated by t test and the difference was statistically analyzed; cdc-42 was used as the internal reference gene to normalize the initial template amount. The primer sequences used are shown in Table 3:

[0086] Table 3 RT-qPCR primer sequences (5'→3')

[0087]

[0088] 3. Experimental results

[0089] The results are as follows Figure 3 As shown in (B), by detecting the transcription levels of DAF-16 downstream target genes (sod-3 and rgs-10), the mechanism by which UDP-glucuronic acid delays aging in nematodes was further analyzed. It was found that UDP-glucuronic acid significantly promoted the transcription of sod-3 and rgs-10. These results further indicate that the life-extending effect of UDP-glucuronic acid depends on the activation of DAF-16.

[0090] Example 5 Analysis of the mechanism of UDP-glucuronic acid delaying aging in nematodes

[0091] 1. Purpose of the experiment

[0092] To explore the mechanism by which uridine diphosphate glucuronide delays aging in nematodes.

[0093] 2. Experimental methods

[0094] All lifespan experiments were performed at 20 °C. Before the lifespan experiment, CB1370 daf-2 (e1370) mutant nematodes were cultured on fresh NGM plates for 2 to 3 generations, and the nematodes were not subjected to any starvation stimulation. Then, they were synchronized according to the synchronization process of nematodes to obtain nematodes that were assimilated to the L1 stage. The L1 stage nematodes were continued to be cultured on NGM plates until the late L4 or early adult stage. More than 100 nematodes in the late L4 or early adult stage were picked on FUDR plates, and control and experimental groups were set up. The control group was a normal FUDR plate, and the experimental group was a FUDR plate containing 0.5 mM UDP-glucose. The first day of egg laying was recorded as the first day of adult lifespan. In order to ensure the efficacy of the drug throughout the life cycle, the nematodes in the control and experimental groups were transferred to fresh corresponding FUDR plates every other day. The number of nematodes that survived was counted every day until all the nematodes died. In the lifespan statistics, if the nematodes could not respond to external mechanical stimulation (such as knocking on the plate), they were recorded as dead. Nematodes that crawled out of the plate, had genital pores protruding, or larvae hatched in the body were not counted as dead. The experimental results were analyzed by SPSS software, and the data were expressed as Kaplan-Meier survival curves. Statistical differences were calculated by log-rank test. Three biological replicates were performed for each group of lifespan experiments.

[0095] 3. Experimental results

[0096] The results are as follows Figure 4As shown in Table 4, based on the fact that DAF-16 is an important transcription factor downstream of the insulin signaling pathway, and considering that UDP-glucuronic acid extends lifespan depends on the regulation of DAF-16, it is speculated that it may be possible to regulate the insulin signaling pathway. Therefore, a survival analysis was performed on the nematode CB1370 daf-2 (e1370) with partial loss of function of the insulin receptor DAF-2. It was found that UDP-glucuronic acid could not further extend the lifespan of the mutant, indicating that the lifespan-extending effect of UDP-glucuronic acid is achieved by inhibiting DAF-2.

[0097] Table 4 Effect of UDP-glucuronidase on the lifespan of CB1370 daf-2(e1370) mutant

[0098] UDP-glucuronic acid concentration Mean life span ± SEM (days) #timg#value % Elongation Number of samples Experiment 1 0 53.695±0.323 128 0.5 53.525±0.335 0.695 # 118 Experiment 2 0 53.813±0.312 144 0.5 52.860±0.335 0.043 # 121 Experiment 3 0 53.143±0.344 105 0.5 52.556±0.353 0.201 # 99

[0099] Table 4: The lifespan experiment was analyzed using SPSS software Kaplan-Meier, and the statistical difference (P value) was calculated using log-rank test; N is the number of nematodes included in the final statistical results of the experiment; # indicates that no calculation was performed (because P>0.05). The experiment was repeated three times independently.

[0100] Example 6 Analysis of the mechanism of UDP-glucuronic acid delaying aging in nematodes

[0101] 1. Purpose of the experiment

[0102] To explore the mechanism by which uridine diphosphate glucuronide delays aging in nematodes.

[0103] 2. Experimental methods

[0104] All lifespan experiments were performed at 20 °C. PS3551 hsf-1 (sy441) mutant nematodes were cultured on fresh NGM plates for 2-3 generations, and the nematodes were not subjected to any starvation stimulation. Then, the nematodes used for lifespan experiments were synchronized according to the synchronization process of nematodes to obtain nematodes assimilated to the L1 stage. The L1 stage nematodes were continued to be cultured on NGM plates until the late L4 or early adult stage. More than 100 nematodes in the late L4 or early adult stage were picked on FUDR plates, and control and experimental groups were set up. The control group was a normal FUDR plate, and the experimental group was a FUDR plate containing 0.5 mM UDP-glucose. The first day of egg laying was recorded as the first day of adult lifespan. In order to ensure the efficacy of the drug throughout the life cycle, the nematodes in the control group and the experimental group were transferred to fresh corresponding FUDR plates every other day. The number of nematodes that survived was counted every day until all the nematodes died. In the lifespan statistics, if the nematodes could not respond to external mechanical stimulation (such as knocking on the plate), they were recorded as dead. Nematodes that crawled out of the plate, had genital pores protruding, or larvae hatched in the body were not counted as dead. The experimental results were analyzed by SPSS software, and the data were expressed as Kaplan-Meier survival curves. Statistical differences were calculated by log-rank test. Three biological replicates were performed for each group of lifespan experiments.

[0105] 3. Experimental results

[0106] The results are as follows Figure 5 As shown in (A) and Table 5, in addition to DAF-16, there is another transcription factor HSF-1, which is also an important stress response factor in the downstream transcription factor of the insulin signaling pathway. Therefore, a survival analysis of the HSF-1 loss-of-function mutant nematode PS3551 hsf-1 (sy441) was performed, and it was found that UDP-glucuronidase could not further extend the lifespan of the mutant.

[0107] Table 5 Effects of UDP-glucose on the lifespan of the PS3551 hsf-1 (sy441) mutant

[0108]

[0109] Table 5: The lifespan experiment was analyzed using SPSS software Kaplan-Meier, and the statistical difference (P value) was calculated using log-rank test; N is the number of nematodes included in the final statistical results of the experiment; # indicates that no calculation was performed (because P>0.05). The experiment was repeated three times independently.

[0110] Example 7 Analysis of the mechanism of UDP-glucuronic acid delaying aging in nematodes

[0111] 1. Purpose of the experiment

[0112] To explore the mechanism by which uridine diphosphate glucuronide delays aging in nematodes.

[0113] 2. Experimental methods

[0114] (1) Before RNA extraction and quantitative PCR (RT-qPCR), wild-type N2 nematodes were cultured on fresh NGM plates. They were synchronized according to the synchronization process of nematodes to obtain nematodes that were assimilated to the L1 stage. About 2,000 synchronized wild-type N2 nematodes at the L1 stage were cultured on NGM plates. A control group and an experimental group were set up. The control group was a normal NGM plate, and the experimental group was an NGM plate containing 0.5 mM UDP-glucuronic acid. On the first day of adulthood, the nematodes were rinsed and washed with M9 solution and collected. Centrifuge, aspirate all the supernatant, and place in liquid nitrogen for 10 s. Add 0.5 mL Trizol to fully homogenize and let stand at room temperature for 5 min.

[0115] (2) Add 0.2 mL of chloroform per 1 mL of Trizol solution, mix thoroughly, and let stand at room temperature for 10 min.

[0116] (3) Centrifuge at 4°C and 12,000 rpm for 15 min. The sample will separate into three layers. The upper layer is the RNA layer.

[0117] (4) Add an equal volume of isopropanol to the RNA solution, mix well, leave at room temperature for 10 min, and centrifuge at 4°C, 12,000 rpm for 10 min.

[0118] (5) Discard the waste liquid, add 1 mL of 75% ethanol to wash the precipitate (4°C, 20 min), centrifuge at 12,000 rpm for 3 min at 4°C, and discard the supernatant. The precipitate is RNA, dry it, and add 50 µL of 0.1% DEPC water to dissolve the RNA.

[0119] (6) Detect the purity and concentration of RNA, and then reverse the RNA into cDNA according to the operating procedures of the reverse transcription kit for quantitative PCR.

[0120] (7) Quantitative PCR was performed according to the instructions of the kit. The quantitative results were obtained using 2 -ΔΔCt The differential expression was calculated by t test and the difference was statistically analyzed; cdc-42 was used as the internal reference gene to normalize the initial template amount. The primer sequences used are shown in Table 6.

[0121] Table 6 RT-qPCR primer sequences (5'→3')

[0122]

[0123] 3. Experimental results

[0124] The results are as follows Figure 5 As shown in (B), by detecting the transcription levels of HSF-1 downstream target genes (hsp-16.2 and hsp-12.6), it was found that UDP-glucuronic acid significantly promoted the transcription of hsp-16.2 and hsp-12.6. These results further indicate that the life-extending effect of UDP-glucuronic acid depends on the activation of HSF-1.

[0125] The above embodiments are preferred implementation modes of the present invention, but the implementation modes of the present invention are not limited to the above embodiments. Any other changes, modifications, substitutions, combinations, and simplifications that do not deviate from the spirit and principles of the present invention should be equivalent replacement methods and are included in the protection scope of the present invention.

Claims

1. Use of uridine diphosphate glucuronic acid in the preparation of anti-aging drugs, characterized in that: The concentration of the UDP-glucuronic acid is 0.1 mM to 2 mM.

2. The application according to claim 1, characterized in that: The anti-aging effect is to inhibit the body's insulin receptors.

3. The application according to claim 2, characterized in that: The insulin receptor is DAF-2.

4. The application according to claim 2, characterized in that: The UDP-glucuronic acid inhibits the body's insulin receptors by regulating the insulin signaling pathway.

5. The use according to claim 1, characterized in that: The anti-aging effect is to activate the body's downstream transcription factors.

6. The use according to claim 5, characterized in that: The downstream transcription factor is DAF-16.

7. The use according to claim 5, characterized in that: The downstream transcription factor is HSF-1.

8. The use according to claim 1, characterized in that: The dosage form of the anti-aging drug is an injection, a spray or an oral solution.

Citation Information

Patent Citations

  • Application of nicotinamide mononucleotide in preparation of anti-aging drugs or health care products

    CN104814974A

  • Oligonucleotides for modulating ATXN2 expression

    CN112912500A

  • Application of 5'-nucleotide or mixture thereof in preparation of medicine or functional food for improving senescence cell metabolism

    CN113476470A

  • Catalytic characteristics of lesion mimic gene UAP1, and applications thereof

    CN106167804A

  • Method for manufacturing 3-o-xylosyl quercetin from quercetin using microorganism mutants

    KR1020140005675A